Literature DB >> 29039552

Prospective lncRNA-miRNA-mRNA regulatory network of long non-coding RNA LINC00968 in non-small cell lung cancer A549 cells: A miRNA microarray and bioinformatics investigation.

Dong-Yao Li1, Wen-Jie Chen1, Lei Luo1, Yong-Kun Wang1, Jun Shang1, Yu Zhang2, Gang Chen2, Shi-Kang Li1.   

Abstract

Accumulating evidence suggests that the dysregulation of long non-coding RNAs (lncRNAs) serves vital roles in the incidence and progression of lung cancer. However, the molecular mechanisms of LINC00968, a recently identified lncRNA, remain unknown. The objective of present study was to investigate the role of a prospective lncRNA-miRNA‑mRNA network regulated by LINC00968 in non-small cell lung cancer cells. Following the transfection of lentiviruses carrying LINC00968 into A549 cells, the microRNA (miRNA) expression profile of the cells in response to the overexpression of LINC00968 was detected using an miRNA microarray. Five differentially expressed miRNAs (DEMs) with LINC00968 overexpression were obtained, including miR-9-3p, miR‑22-5p, miR-668-3p, miR‑3675-3p and miR-4536-3p. Five target prediction algorithms and three target validation algorithms were used to obtain 1,888 prospective target genes of the five DEMs. The result of Gene Ontology analysis suggested that these five DEMs were involved in complex cellular pathways, which included intracellular transport, organelle lumen and nucleotide binding. Furthermore, analysis of Kyoto Encyclopedia of Genes and Genomes pathways indicated that the five DEMs were important regulators in the adherens junction and focal adhesion. An lncRNA-miRNA-mRNA regulatory network and a protein-protein interaction network were then constructed. Eventually, a prospective lncRNA‑miRNA-mRNA regulatory network of LINC00968, three miRNAs (miR-9, miR-22 and miR-4536) and two genes (polo-like kinase 1 and exportin-1) was obtained following validation in the Cancer Genome Atlas database. These results may provide novel insights to support future research into lncRNA in lung cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29039552     DOI: 10.3892/ijmm.2017.3187

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  23 in total

1.  Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.

Authors:  Guang-Hui Li; Zhong-Hui Ma; Xi Wang
Journal:  Cell Cycle       Date:  2019-09-04       Impact factor: 4.534

2.  Circ_CSPP1 Regulates the Development of Non-small Cell Lung Cancer via the miR-486-3p/BRD9 Axis.

Authors:  Dan Xie; Shuyi Zhang; Xiaocong Jiang; Weizhen Huang; Ying He; Yi Li; Sihan Chen; Hailin Xiong
Journal:  Biochem Genet       Date:  2022-06-09       Impact factor: 1.890

3.  Long noncoding RNA LINC00968 inhibits proliferation, migration and invasion of lung adenocarcinoma through targeting miR-22-5p/CDC14A axis.

Authors:  Chao Wu; Xuzhao Bian; Liyuan Zhang; Yuanyuan Hu; Yang Wu; Tianli Pei; XinPeng Han
Journal:  3 Biotech       Date:  2021-09-14       Impact factor: 2.893

4.  Long noncoding RNA LINC01296 plays an oncogenic role in colorectal cancer by suppressing p15 expression.

Authors:  Jianing Xu; Zhehao Zhang; Dong Shen; Ting Zhang; Jinsong Zhang; Wei De
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

5.  Upregulated lncRNA CASC9 Contributes to Progression of Non-Small Cell Lung Cancer Through Inhibition of miR-335-3p and Activation S100A14 Expression.

Authors:  Weigang Zhao; Tangbing Chen; Yonghong Zhao
Journal:  Onco Targets Ther       Date:  2020-06-24       Impact factor: 4.147

Review 6.  Non-coding RNAs in cancer: platforms and strategies for investigating the genomic "dark matter".

Authors:  Katia Grillone; Caterina Riillo; Francesca Scionti; Roberta Rocca; Giuseppe Tradigo; Pietro Hiram Guzzi; Stefano Alcaro; Maria Teresa Di Martino; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  J Exp Clin Cancer Res       Date:  2020-06-20

7.  Comparison of tumor related signaling pathways with known compounds to determine potential agents for lung adenocarcinoma.

Authors:  Song Xu; Renwang Liu; Yurong Da
Journal:  Thorac Cancer       Date:  2018-06-05       Impact factor: 3.500

8.  LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling.

Authors:  Hua Liu; Haoyu Deng; Yajie Zhao; Can Li; Yu Liang
Journal:  J Exp Clin Cancer Res       Date:  2018-11-21

9.  Knockdown long non-coding RNA ANRIL inhibits proliferation, migration and invasion of HepG2 cells by down-regulation of miR-191.

Authors:  Deyu Huang; Chunhua Bi; Qingxi Zhao; Xueli Ding; Cheng Bian; Hui Wang; Ting Wang; Hua Liu
Journal:  BMC Cancer       Date:  2018-09-24       Impact factor: 4.430

10.  The impact of miR-9 in osteosarcoma: A study based on meta-analysis, TCGA data, and bioinformatics analysis.

Authors:  Fengfeng Wu; Xuesheng Jiang; Qun Wang; Qian Lu; Fengxiang He; Jianyou Li; Xiongfeng Li; Mingchao Jin; Juntao Xu
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.